Showing results (301-310 of 412) with videos related to

Sort By:
Pageof 42
Blood|March 23, 2006
Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukemiaCharles Koller, B Nebiyou Bekele, Xian Zhou, et al.
Transfusion|June 28, 2017
Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor-mutated essential thrombocythemiaCelina Montemayor-Garcia, Rebecca Coward, Maher Albitar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignanciesDavid A Rizzieri, Eric Feldman, John F Dipersio, et al.
Cancers|February 26, 2025
Updates on the Biological Heterogeneity of Mantle Cell LymphomaAndrew Ip, Maciej Kabat, Lindsay Fogel, et al.
Cancer|February 25, 2003
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndromeJorge Cortes, Hagop Kantarjian, Maher Albitar, et al.
Cancer|March 11, 2003
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromesApostolia Tsimberidou, Elihu Estey, Jorge Cortes, et al.
American Journal of Clinical Pathology|October 12, 2002
Differences in CD33 intensity between various myeloid neoplasmsIman Jilani, Elihu Estey, Yang Huh, et al.
British Journal of Haematology|May 4, 2011
Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 studyPaul G Richardson, Asher A Chanan-Khan, Sagar Lonial, et al.
Leukemia|July 29, 2005
Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemiasH M Amin, Y Yang, Y Shen, et al.
Cancer|March 17, 2004
Thalidomide for patients with recurrent lymphomaBarbara Pro, Anas Younes, Maher Albitar, et al.
Pageof 42